Objective IL-5 is strongly involved in the eosinophilic inflammation in bronchial asthma and atopic dermatitis. Wehave previously reported that IL-5 synthesis in atopic and nonatopic asthmatics is significantly enhanced compared to control subjects. T cell IL-5 synthesis is regulated through several transcriptional elements, one of which is the proximal human IL-5 promoter (-62 to -46). The present study was undertaken to delineate the transcriptional regulation through this element using nontransformed human T cells. Methods Con A blast lymphocytes which tolerate electroporation were derived from peripheral blood lymphocytes. Luciferase reporter analysis and gel shift analysis were performed. Results The proximal promoter element is the overlapping binding site for the constitutive binding factor, Oct-1, and the inducible one, AP-1. The transcriptional induction was ascribed to the inducible binding, while the constitutive binding was rather inhibitory. A mutant element which lost the constitutive binding but retained the inducible binding exerted 3 times more transcriptional activity compared to the wild type element. In contrast, another mutant element which lost the inducible binding and retained the constitutive binding exhibited no transcriptional induction. Gel shift analysis clarified that the inducible binding was more prominent and the constitutive binding was less in IL-5-producing T cells derived from asthma patients compared to IL-5-nonproducing cells derived from control subjects. Conclusions The ratio of the inducible/constitutive binding to the proximal promoter element maydetermine the capacity of human Th cells to transcribe IL-5 gene, and its regulation may control eosinophilic inflammation. (Internal Medicine 39: 618-625, 2000) 
Introduction
Bronchial asthma is characterized by persistent eosinophilic inflammation of the bronchial mucosa (1 , 2) . T cell cytokines including interleukin-5 (IL-5) are closely involved in the local infiltration and activation of eosinophils (2, 3) . IL-5 is a potent selective growth factor, differentiation factor, activating factor and chemotactic factor for human eosinophils (4, 5) . The number of CD4+T cells expressing IL-5 mRNAis increased in the bronchial mucosa of symptomatic asthmatic patients (6) , is correlated with the numberof activated eosinophils, and is further increased upon allergen inhalation challenge (7, 8) . Bronchoalveolar lavage (BAL) fluid obtained from atopic and non-atopic asthmatics showedan increased concentration of IL-5 (9) . IL-5 is the predominant eosinophil-active cytokine present in the BALfluid obtained from asthmatic patients ( 10) .
SerumIL-5 concentration was elevated in symptomatic asthmatics and decreased after oral prednisolone therapy ( 1 1 ). The intensity of IL-5 mRNAexpression correlated well with that of eosinophilic infiltration, whereas that of IL-3 and GM-CSF did not (12) . Wehave reported that IL-5 production by CD4+T cells of asthmatic patients is significantly enhanced compared to that of healthy controls (13) . Several experimental asthma models revealed that administration of anti-IL-5 neutralizing antibody inhibited the recruitment of eosinophils into the lung and abrogated the late phase bronchoconstriction (14) (15) (16) (17) , clearly indicating the essential role of IL-5 in the late phase asthmatic response. T cells producing IL-3, GM-CSF,and IL-5 were also demonstrated in the late phase cutaneous reaction of atopic dermatitis patients upon antigen challenge (18) . Accumulating evidence including the above-mentioned studies has suggested that IL-5 is the key cytokine involved in the allergic disorders associated with eosinophilic inflammation. The regulation of T cell IL-5 synthesis maybe an effective management for eosinophilic disorders.
IL-2 and IL-4 synthesis by helper T (Th) cells is mainly
Control of IL-5 Gene in HumanT Cells lyzed murine IL-5 promoter/enhancer gene. GATA-3 element and conserved lymphokine element 0 (CLEO) of the murine IL-5 enhancer gene are important for the response to CAMP (23) . PMAresponsive element, designated as IL-5P (-117 to -92), is related to NF-AT binding factors (24) . TCATTT-binding factor was induced upon stimulation and downregulated by cyclosporin A (25) . Positively regulating elements (-244 to -81) and negatively regulating elements (-431 to -392 and -300 to -261) have also been located in the murine IL-5 gene (26) . Somestudies even utilized murine EL4cells to analyze human IL-5 gene (27, 28) because of the lack of appropriate human T cell systems. As to human T cell IL-5 synthesis, Yamagataet al employed a humanT cell leukemia virus type I (HTLV-I)-transformed cell line which constitutively produced high amounts of various cytokines (29) , and reported that GATA-4binding was important. Wehave established allergen-specific Th clones and hybridomas from the peripheral lymphocytes of asthma patients. The correlation between protein production and gene transcription of IL-5 was first determined using human Th clones (30) . IL-5 protein production of Th clones was associated with the inducible transcriptional activity of IL- not express this factor. Transcriptional factor (s) that differentially dysregulate IL-5 gene may be involved in the development of eosinophilic disorders including bronchial asthma and atopic dermatitis. Elucidation of such mechanisms will greatly improveour understanding of the molecular pathogenesis of allergic diseases and might facilitate the development of novel therapeutic intervention which specifically downregulates IL-5 gene transcription without affecting other T cell functions.
Our previous study indicated that the proximal promoter element (-61 to -42 relative to the transcription initiation site) is essential for the transcriptional induction of human IL-5 gene (3 1). The element is highly homologous to the conserved lymphokine element (CLE) 0 which has been identified in IL-3 and GM-CSFgenes (32) . The element is the target of at least two binding factors, one inducible and the other constitutive, which seem mutually exclusive. The constitutive band was identified as Oct-1 molecule, whereas the inducible band comprised ofAP-1 family proteins. Serial 2 bp mutagenesis introduced in this element successfully differentiated the two binding complexes (33) . The mutant element which lost constitutive binding but retained inducible binding exerted 3 times more transcriptional activity compared to the wild type element. In contrast, another mutant element which lost inducible binding and retained constitutive binding exhibited no transcriptional induction, indicating that the transcriptional induction was ascribed to the inducible binding, and the constitutive binding was transcriptionally inactive. In the present study, transcriptional regulation of IL-5 gene through the proximal element and its binding factors was examinedfor the first time employing Con A blast lymphocytes obtained from asthma patients as nontransformed humanT cells.
Materials and Methods

Subjects
Adult atopic asthma patients referred to the Allergy Clinic at National Sagamihara Hospital were enrolled in this study. All patients were non-smokers and fulfilled the criteria of the International Consensus Report on Diagnosis and Management of Asthma (34) , and all demonstrated at least 20% improvement of their FEV, 0 after p2-agonist inhalation. Atopy was defined as the detection of one or more positive skin prick tests to a range of 20 common airborne allergens in the presence of a positive histamine control and a negative vehicle control. Patients receiving systemic qr inhaled corticosteroids were excluded from the study. Treatment with j32-stimulants, anticholinergics, and theophylline was stopped at least 12 hours before blood sampling. The control subjects were healthy ageand sex-matched individuals with normal IgE levels, negative skin prick tests, no history of allergy or asthma, and no medications. All subjects gave written informed consent to the protocol as approved by the Institution's Ethics Committee.
Reagen ts Phorbol 1 2-myristate 1 3-acetate (PMA) was purchased from Sigma (St. Louis, MO), and ionomycin (IOM) was purchased from Calbiochem (La Jolla, CA). Concanavalin A (Con A) was from Pharmacia Biotech (Uppsala, Sweden). Recombinant human IL-2 (rIL-2) was provided by Shionogi Pharmaceutical Co. (Osaka). AIM-Vmedium and RPMI1640 medium (Gibco BRL, Gaithersburg, MD) were used for culturing T cells.
Con A blast lymphocytes Peripheral blood mononuclear cells (PBMC)were prepared by Ficoll-Paque density gradient centrifugation as described previously (13) . Cells (2xlO6/ml) were cultured with Con A (3 (ig/ml) in RPMI 1,640 medium containing 10% fetal calf serum (FCS) for 3 days. Non-adherent cells increased in number by three to five fold. Cells were subsequently maintained in fresh AIM-Vmedium containing 10% FCS and 10 U/ml r IL-2 for 6-7 days. Then, Con A blast lymphocytes were harvested, washed twice, and resuspended in fresh medium. The resulting preparation usually consisted of more than 95%CD3-positive cells, as determined by flow cytometry.
Cell Separation CD4-or CD8-positive cells were depleted from the Con A blast lymphocytes using anti-CD4 or anti-CD8-coupled magnetic beads (Dynal, Great Neck, NY), respectively, according to the manufacturer's directions. The efficiency of the depletion was determined by FACSanalysis. Less than 5% positive cells remained after each depletion procedure.
Quantitation of cytokines in culture supernatants IL-5 was measured by a sandwich enzyme-linked immunosorbent assay (ELISA) using monoclonal anti-human IL-5 (D138) as the capture antibody and biotinylated purified rabbit anti-human IL-5 as the second antibody, as described previously (13) .
Plasmid cons tructs PIL-5(-5 1 1)Luc, a human IL-5 promoter/enhancer (-5 1 1 to +4 relative to the transcription initiation site)-luciferase gene construct, was prepared as described previously (35) . The reporter constructs (3xCLE0-tk-Luc, 3xCLE0mt6-tk-Luc, and 3xCLE0mt7-tk-Luc) were generated by cloning three copies of the corresponding oligonucleotides as direct repeats into the Xho I and Hind III sites of the pGL3-tk vector, which carries the truncated thymidine kinase (tk) promoter connected to the luciferase reporter gene. Identity of the promoter/enhancer sequence was confirmed by chain termination sequencing using Sequenase 2.0 (Strategene). PCMV-p-gal control vector (Riken DNABank:, Tokyo) was used as a transfection control.
Transient transfection, luciferase assay, and b-galactosidase assay Con A blast lymphocytes (107 cells) were suspended in 500
(il CRPMI 1,640 medium containing 10 U/ml rIL-2 in a 0.4 cm electroporation cuvette, incubated with 50 |LLg luciferase reporter plasmids and 10 \ig PCMV-p-gal, and then transfected by electroporation using a Gene Pulser (Bio-Rad, Richmond, CA) at 300 V, 960 |iF with a mean time constant of 20 msec. Transfected cells were pooled and 4xlO6 cells per well were cultured in 24-well culture plates with or without stimulation for 24 hours. Protein extracts were then prepared and luciferase activity was assayed using the Luciferase Assay System (Promega). p-Galactosidase activity was assayed using chlorophenol red-P-D-galactopyranoside (CPRG) as the substrate, as described previously (35) .
Preparation of nuclear extracts and Electrophoretic mobility shift assay (EMSA) Crude nuclear and cytoplasmic extracts were prepared from unstimulated or stimulated cells as described by Schreiber et al (36) with modifications. Pairs of synthetic HPLC-purified oligonucleotides (Sawady Technology, Tokyo) containing complementary sequences were annealed by boiling equimolar concentrations of each strand for 10 minutes and the mixture was allowed to slowly cool in a water bath to room temperature. EMSAwas performed using 32P end-labeled oligonucleotides as described previously (37, 38 
Results
Transcriptional induction through the proximal promoter element by the inducible binding factor
The first experiment was performed to determine the role of the proximal promoter element in the transcriptional induction of IL-5 gene by nontransformed human T cells. As the resting peripheral lymphocytes were not sufficiently efficient for transfection experiments, Con A blast lymphocytes were derived from peripheral blood mononuclear cells, and tested for the transcriptional activity. Con A blast lymphocytes derived from asthmatic donors produced a significant amount of IL-5 and transcribed PIL-5(-5 1 1)Luc upon stimulation with PMA(20 nM) plus ionomycin (1 |jM), whereas the cells derived from healthy controls scarcely produced IL-5 nor transcribed pIL-5(-51 1)Luc (39) . Those cells that produced more than 100 pg/ ml, 10 to 100 pg/ml, and less than 10 pg/ml of IL-5 were designated as IL-5 high-, low-, and non-producing cells, respectively. Cell depletion experiment using magnetic beads coated with anti-CD4 or CD8 antibodies revealed that CD4+ T (Th) cells were solely responsible for IL-5 production, as IL-5 production was totally abrogated by the depletion of CD4T cells but not CD8T cells (Table 1) . Transcriptional activity mediated by this element was analyzed by transfecting the Con A blast lymphocytes with 3xCLE0-tk-Luc. As shown in Table 2 , 3xCLE0-tk-Luc was clearly induced upon activation by IL-5 high-producing ConA blast lymphocytes derived from asthmatic donors, but not by the cells derived from control donors which produced no detectable IL-5, indicating a differential regulation of this promoter among IL-5 high-, low-, and nonproducing T cells. The transfection efficiency was determined aCon A blast lymphocytes were derived from the peripheral blood mononuclear cells obtained from asthmatic patients and healthy control subjects. bH; IL-5 high-producing (>100 pg/ml), L; low-producing (10 to 100 pg/ml), N; non-producing (<10 pg/ml). CA; asthmatic donors, C; healthy control donors. dCon A blast lymphocytes were incubated with magnetic beads coated with either control IgG, anti-CD4, or anti-CD8 antibody. Unbound cell fractions (105 /well) were cultured in triplicate in 96-well round bottom culture plates with PMA (20 nM) plus ionomycin (1 jLiM) or left unstimulated. The supernatants were collected after 24 hours and assayed for IL-5 with a specific ELISA.Data are presented as the meanof triplicate cultures ± SEM.IL-5 production of the cultures without stimulation was below the detection limit of the ELISA (1 pg/ml). aCon A blast lymphocytes were derived from the peripheral blood mononuclearcells obtained from asthmatic patients and healthy control subjects. bH; IL-5 high-producing (>100 pg/ml), L; low-producing (10 to 100 pg/ml), N; non-producing (<10 pg/ml). CA; asthmatic donors, C; healthy control donors. dCon A blast lymphocytes (105 / well) were cultured in triplicate in 96-well round bottom culture plates with PMA (20 nM) plus ionomycin (1 jjM) or left unstimulated. The supernatants were collected after 24 hours and assayed for IL-5 with a specific ELISA.Data are presented as the meanof triplicate cultures ± SEM.IL-5 production of the cultures without stimulation was below the detection limit of the ELISA(1 pg/ml). eCon A blast lymphocytes were transiently transfected with 3xCLE0-tk-Luc (50 jug) + PCMV-p-gal (10 |Xg) by electroporation (300 V, 960^F) using a 0.4 cmcuvette. Cells were either stimulated with PMA(20 nM)plus ionomycin (1 jliM) or kept unstimulated in 24-well culture plates as indicated. After 24 hours, cell lysates were prepared and tested for luciferase activity using Luciferase Assay System (Promega) and p- by the cotransfection with CMV-0-gal, and did not differ significantly among these cell preparations (data not shown). To elucidate the role of two complexes binding to the proximal promoter element of human IL-5 gene, 3xCLE0-tk-Luc, 3xCLE0mt6-tk-Luc, and 3xCLE0mt7-tk-Luc constructs were transfected into the IL-5 high-producing Con A blast lymphocytes, and the resultant transcriptional induction was analyzed. As previously reported, CLE0mt6 oligonucleotide retains the inducible binding (AP-1) and loses the constitutive binding (Oct-1), whereas CLEmt?oligonucleotide loses the inducible binding and retains the constitutive binding (33) . A representative result of three independent experiments is shown in Fig. 1. 3xCLE0mt6-tk-Luc was induced more vigorously than the wild type gene construct, whereas 3xCLE0mt7-tk-Luc exhibited no transcriptional induction, suggesting that the inducible binding factor is responsible for the transcriptional activation through this element, and the constitutive binding factor functions as a negative regulator. Significant induction of luciferase activity was not detected by transfecting IL-5 low-and nonproducing Con A blast lymphocytes with these three constructs (data not shown), consistent with the lower transcriptional induction of PIL-5(-5 1 l )Luc compared with IL-5 high-producing Con A blast lymphocytes ( Table 2) . The results are consistent with our previous findings obtained using human T cell hybridomas that transcribe IL-5 gene upon activation (33) , and further extend that the transcriptional regulation through the proximal promoter element is essential for the nontransformed humanT cells which might work in asthmatic patients in vivo.
Difference in the proximal promoter binding complexes between IL-5-producing and -nonproducing human Con A blast lymph ocytes IL-5 high-producing Con A blast lymphocytes were stimulated with 20 nM PMAand 1 jxM IOM for 2 hours, and then nuclear extracts were prepared for EMSA. As shownin Fig.  2A , a constitutive binding complexwas observed using nuclear extract obtained from the unstimulated cells (lane 1). Upon stimulation, the inducible band with a faster mobility became detectable (lane 2). The CLE0mt6oligonucleotide competed out the faster migrating complex (lane 4), whereas the CLE0mt7 oligonucleotide competedout the slower migrating complex (lane 6), thus confirming these mutagenesis effects previously reported by us (33) . The proximal promoter binding complexes were next characterized among IL-5 high-, low-, and non-producing Con A blast lymphocytes. IL-5 high-and low-producing Con A blast lymphocytes were derived from asthma patients, while IL-5 non-producing Con A blast lymphocytes were derived from control subjects. As shown in Fig. 2B , the inducible binding complex was prominent in IL-5 high-producing cells, but scarcely detectable in the IL-5 low-and non-produc- ing cells. The ratio of the inducible binding/the constitutive binding was high in the IL-5 high-producing cells, and low in the IL-5 low-and non-producing cells (Fig. 2C) . Essentially the same result was obtained employing three asthmatic donors and three control donors (data not shown).
Discussion
The present findings clearly indicate that the proximal promoter element regulates the transcriptional induction of IL-5 gene in nontransformed human Th cells. The ratio of the inducible factor/the constitutive factor might determine the on/ off of the IL-5 gene transcription of Th cells, which is enhanced in eosinophilic disorders.
As IL-5 is a potent growth factor and activating factor for human eosinophils (4, 5) , great attention has been paid to the relationship between IL-5 production and the eosinophilic inflammation. Upregulation of protein and mRNA expression of IL-5 was demonstrated in the bronchial mucosa of atopic and nonatopic asthma patients, which well correlated with the intensity of the infiltration and activation status of eosinophils (6, 40, 41) . Wereported that mice adoptively transferred IL-5-producing Th clones developed airway eosinophilic inflammation and bronchial hyperresponsiveness upon inhalation of the relevant antigen, clearly indicating the importance of Th cells as the source of IL-5 (42). IL-5 production by CD4+ T cells of asthmatic patients is significantly enhanced compared to that of healthy controls (13) . In addition, glucocorticoids and FK506 not only suppress IL-5 synthesis in vitro, but also reduce IL-5 production by peripheral Th cells in parallel with the clinical improvement (13, 43) . It is, thus, suggested that enhanced IL-5 production by Th cells is characteristic of allergic diseases associated with eosinophilic inflammation, and its correction is an effective therapeutic target. Elucidation of the regulatory mechanismsinvolved in the selectively enhanced gene transcription of IL-5 seems to be essential to understand the molecular basis of the allergic inflammatory diseases such as bronchial asthma, atopic dermatitis, and allergic granulomatous angitis.
It is well knownthat synthesis of major T cell cytokines such as IL-2 and IL-4 is transcriptionally regulated (19) (20) (21) 44) . To date, the information on human IL-5 gene transcription is still limited, while quite a few studies have been performed to analyze murine IL-5 gene (23-26, 45, 46) . We have employed allergen-specific Th clones and hybridomas to study cytokine synthesis involved in allergic inflammation (47) , and found that human T cell IL-5 synthesis is regulated at the level of gene transcription through the 5 15 bp gene segment 5' upstream of the coding region, and unique transcriptional mechanisms distinct from those regulating IL-2 or IL-4 gene seemed to control IL-5 gene (37, 38, 48, 49 ). The present finding that transcriptional activity of IL-5 promoter by Con A blast lym- phocytes is correlated with the protein production further support the notion. Of note is that IL-5 high-producing Con A blast lymphocytes can be derived from asthmatic donors and not from control donors as wehave reported (39) . Transcriptional regulation of human IL-5 gene through the proximal promoter element was previously studied employing T cell hybridomas (3 1). The present study clarified for the first time that the proximal promoter element is involved in the activation of IL-5 gene by Con A blast lymphocytes, non-transformed human T cells. An inducible binding complex which is comprised of AP-1 family proteins and a constitutive binding complex which was identified as Oct-1 molecule were also detected for Con A blast lymphocytes (Fig. 2) . The essential role of the inducible binding was demonstrated employing the mt7 mutant element which lost inducible binding but retained constitutive binding capacity (Fig. 1 ) . IL-5 high-producing cells exhibited a higher level of inducible binding, suggesting that the more abundant inducible binding complex (I) results in the transcriptional induction in the "allergic" T cells by more frequently replacing the constitutive binding complex (Fig. 3) . The precise molecular nature of inducible binding complex warrants further clarification. Future elucidation of transcription factors involved in IL-5 gene transcription (NF-IL-5) would greatly improve the understanding of atopic diseases associated with eosinophilic inflammation, and facilitate the development of novel therapeutic interventions. 
